Articles & Video
Giving a Pharma Giant a Tech Startup Makeover
This shows how we’re using data and digital to reimagining medicine. If successful, this could open up the entire area of digital therapeutics.
Biotech VC Down 20% in US as Policies Drive Away Foreign Investors, BIO Says
Reforms to a US national security regulation are putting off foreign investors and driving down VC investment in the biotech space by as much as 20 percent, says BIO’s David Thomas.
Pharma embraces biopartnering at BIO-Europe to address its innovation deficit
Big pharma’s appetite for early preclinical assets continues to grow and now represents the development phase with the most deals and largest total deal value. Consequently, an increasing number of academic institutions are taking the opportunity to showcase their efforts in the academic track at BIO-Europe.
Strategies and case studies on diversity from leading life sciences organizations - WHITEPAPER
Diversity in life sciences - This whitepaper looks at case studies of organizations who have successfully developed tools and practices to enhance diversity.
How Life Science Cares is fighting poverty in Boston
Life Science Cares is a collective industry effort that works across companies in the Boston area to fight poverty in the community. Executive Director Sarah MacDonald explains how.
Diversity and inclusion offer visibility for the underrepresented in Life Sciences
Edie Stringfellow, Mass Bio's first ever Director of Diversity and Inclusion, and VisionSpring co-founder Erica Colonero explore the importance of diversity and inclusion.
While diversity is the acceptance of differences inclusion leverages those differences
Karen Albertson, Global Business Director at 3M SPSD, shares her thoughts on the importance of diversity and inclusion in the biotech industry.
"Achieving diversity and inclusion requires engagement from all of us" - Dr. Joan Reede
We spoke with Dr. Joan Reede, Dean for Diversity and Community Partnership at Harvard Medical School on the need to keep having conversations around diversity and inclusion to enforce the changes we want to see.
Biotechs must focus on inclusion to heighten diversity
The biotech industry must focus on inclusion to heighten diversity.
Diversity and Inclusion a hot topic at Biotech Week Boston
Panelists from An Evening of Diversity and Inclusion Dinner at Biotech Week Boston share their expert opinion on why it's important to have more diversity and inclusion in biotech and pharma.